These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32957376)

  • 1. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
    Deng B; Wang M; Liu Z
    Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
    Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
    Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures.
    Huang B; Xin C; Yan H; Yu Z
    Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Chronic Pancreatitis Associated microRNAs and Genes for the Diagnosis of Pancreatic Cancer.
    Gong J; Zhang Q; Peng Q; Shi D
    Am Surg; 2024 Nov; 90(11):2797-2807. PubMed ID: 38708574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs in association with pancreatic cancer risk within 5 years.
    Wang C; Cai H; Cai Q; Wu J; Stolzenberg-Solomon R; Guo X; Zhu C; Gao YT; Berlin J; Ye F; Zheng W; Setiawan VW; Shu XO
    Int J Cancer; 2024 Aug; 155(3):519-531. PubMed ID: 38602070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
    Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
    Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis.
    Liu L; Zhang J; Wu M; Xu H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):443. PubMed ID: 34530741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
    Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
    Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
    Feng F; Wu J; Gao Z; Yu S; Cui Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.
    Yuan W; Tang W; Xie Y; Wang S; Chen Y; Qi J; Qiao Y; Ma J
    Oncotarget; 2016 Nov; 7(48):80033-80045. PubMed ID: 27713117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.